Ignite Creation Date:
2024-05-06 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05262530
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2022-02-21
Brief Title:
Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors
Sponsor:
BioNTech SE
Organization:
BioNTech SE
Organization Data
Organization:
BioNTech SE
Class:
INDUSTRY
Study ID:
BNT142-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioNTech SE
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None